RENAL IRRITATION AGAINST THE BACKGROUND OF INTOXICATION OF SALTS OF HEAVY METALS


如何引用文章

全文:

详细

Details of pathogenesis, clinical presentation, diagnosis and treatment of nephropathies, induced by lead, cadmium and mercury intoxicationm are discussed.

作者简介

- -

参考

  1. Мухин Н.А., Балкаров И.М., Моисеев С.В. и др. Хронические прогрессирующие нефропатии и образ жизни современного человека. Тер. арх. 2004; 5 - 9.
  2. Wedeen R.P. Occupational and environmental renal disease. Semin. Nephrol. 1997; 17(1): 46 - 53.
  3. Jarup L., Alfven T. Low level cadmium exposure, renal and bone effects--the OSCAR study. Biometals. 2004; 17(5): 505 - 509.
  4. Uetani M., Kobayashi E., Suwazono Y. et al. Investigation of renal damage among residents in the cadmium-polluted Jinzu River basin, based on health examinations in 1967 and 1968. Int. J. Environ. Health Res. 2007; 17(3): 231 - 242.
  5. Jarup L. Cadmium overload and toxicity. Nephrol. Dial Transplant. 2002; 17(Suppl. 2): 35 - 39.
  6. Franko A., Budihna M.V., Dodic-Fikfak M. Long-term effects of elemental mercury on renal function in miners of the Idrija Mercury Mine. Ann. Occup. Hyg. 2005; 49(6): 521 - 527.
  7. Sabolic I. Common mechanisms in nephropathy induced by toxic metals. Nephron Physiol. 2006; 104(3): p107 - p114.
  8. Ekong E.B., Jaar B.G., Weaver V.M. Lead-related nephrotoxicity: a review of the epidemiologic evidence. Kidney Int. 2006; 70(12): 2074 - 2084.
  9. Dunbabin D.W., Tallis G.A., Popplewell P.Y. et al. Lead poisoning from Indian herbal medicine (Ayurveda). Med. J. Aust. 1992; 157(11-12): 835 - 836.
  10. Roche A., Florkowski C., Walmsley T. Lead poisoning due to ingestion of Indian herbal remedies. N. Z. Med. J. 2005; 118(1219): U1587.
  11. Prakash S., Hernandez G.T., Dujaili I. et al. Lead poisoning from an Ayurvedic herbal medicine in a patient with chronic kidney disease. Nat. Rev. Nephrol. 2009; 5(5): 297 - 300.
  12. Gidlow D.A. Lead toxicity. Occup. Med. (Lond). 2004; 54(2): 76 - 81.
  13. Tubbs R.R., Gephardt G.N., McMahon J.T. et al. Membranous glomerulonephritis associated with industrial mercury exposure. Study of pathogenetic mechanisms. Am. J. Clin. Pathol. 1982; 77(4): 409 - 413.
  14. Лебедева М.В., Балкаров И.М., Шовская Т.Н. и др. Свинцовая подагра. Клин. мед. 1995; 3: 103 - 104.
  15. Nordberg G.F. Historical perspectives on cadmium toxicology. Toxicol. Appl. Pharmacol. 2009; 238(3): 192 - 200.
  16. Batuman V. Lead nephropathy, gout, and hypertension. Am. J. Med. Sci. 1993; 305(4): 241 - 247.
  17. Langford N., Ferner R. Toxicity of mercury. J. Hum. Hypertens. 1999; 13(10): 651 - 656.
  18. Lin-Tan D.T., Lin J.L., Yen T.H. et al. Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases. Nephrol. Dial. Transplant. 2007; 22(10): 2924 - 2931.
  19. Lin J.L., Lin-Tan D.T., Li Y.J. et al. Low-level environmental exposure to lead and progressive chronic kidney diseases. Am. J. Med. 2006; 119(8): 707.e1 - e9.
  20. Lin J.L., Lin-Tan D.T., Hsu K.H. et al. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N. Engl. J. Med. 2003; 348(4): 277 - 286.
  21. Goyer R.A. Lead toxicity: current concerns. Environ. Health. Perspect. 1993; 100: 177 - 187.

补充文件

附件文件
动作
1. JATS XML
下载